---
title: "TNDM.US (TNDM.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TNDM.US/news.md"
symbol: "TNDM.US"
name: "TNDM.US"
parent: "https://longbridge.com/en/quote/TNDM.US.md"
datetime: "2026-05-20T11:47:41.948Z"
locales:
  - [en](https://longbridge.com/en/quote/TNDM.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TNDM.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TNDM.US/news.md)
---

# TNDM.US (TNDM.US) — Related News

### [Tandem Diabetes Care Announces Leadership Change, Strategy Unchanged](https://longbridge.com/en/news/286564143.md)
*2026-05-15T12:19:47.000Z*
> Tandem Diabetes Care announced the termination of Executive VP Mark Novara, effective May 18, 2026, while affirming that

### [Top 10 US Stock Losers (5.8)](https://longbridge.com/en/news/285780286.md)
*2026-05-08T22:01:01.000Z*
> Artivion(AORT) fell 28.26%, with a trading turnover 127.8 Million USD, and a year-to-date fell 44.3%. Figs(FIGS) fell 24

### [Buy Rating Reaffirmed on Tandem Diabetes Care as Fundamentals Strengthen; $28 Price Target Maintained](https://longbridge.com/en/news/285653241.md)
*2026-05-08T02:35:31.000Z*
> Analyst Mathew Blackman of TD Cowen has reaffirmed a Buy rating on Tandem Diabetes Care, maintaining a price target of $

### [](https://longbridge.com/en/news/285623265.md)
*2026-05-07T21:21:52.000Z*
> Tandem Diabetes Care shares are trading higher after the company reported better-than-expected Q1 financial results.

### [12 Health Care Stocks Moving In Thursday's After-Market Session](https://longbridge.com/en/news/285623324.md)
*2026-05-07T21:05:51.000Z*
> In Thursday's after-market session, several health care stocks experienced significant movements. Maravai LifeSciences (

### [Tandem Diabetes | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 247.22 M](https://longbridge.com/en/news/285608532.md)
*2026-05-07T20:10:35.000Z*